QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online September 17, 2008
doi: 10.1242/10.1242/jcs.035683

This Article Summary Figures Only Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gordon, W. R. Articles by Blacklow, S. C. Search for Related Content PubMed PubMed Citation Articles by Gordon, W. R. Articles by Blacklow, S. C. Social Bookmarking                         What's this?

The molecular logic of Notch signaling – a structural and biochemical perspective

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA

^* Author for correspondence (e-mail: sblacklow{at}rics.bwh.harvard.edu)

Accepted 5 August 2008

	Summary

Top Summary Introduction Ligand recognition Activation switch Nuclear translocation and... Conclusion and perspectives References

 
The Notch signaling pathway constitutes an ancient and conserved mechanism for cell-cell communication in metazoan organisms, and has a central role both in development and in adult tissue homeostasis. Here, we summarize structural and biochemical advances that contribute new insights into three central facets of canonical Notch signal transduction: (1) ligand recognition, (2) autoinhibition and the switch from protease resistance to protease sensitivity, and (3) the mechanism of nuclear-complex assembly and the induction of target-gene transcription. These advances set the stage for future mechanistic studies investigating ligand-dependent activation of Notch receptors, and serve as a foundation for the development of mechanism-based inhibitors of signaling in the treatment of cancer and other diseases.

Key words: Biological signaling, Protein biochemistry, Receptor, Regulated intramembrane proteolysis, Transcription

	Introduction

Top Summary Introduction Ligand recognition Activation switch Nuclear translocation and... Conclusion and perspectives References

 
Notch receptors are modular, single-pass transmembrane proteins that receive signals from transmembrane ligands that are expressed on neighboring cells. The signals that are transduced by these receptors have a central role in cell-fate decisions, both during embryonic development and in adult tissue homeostasis. The essential role of Notch signaling during development is evident from the embryonic lethality that is associated with deficiencies in Notch signaling in various model organisms, including worms, flies and mice. Notch signals are used iteratively at different decision points to guide functional outcomes that depend heavily on gene dose and signaling context. Significantly, both deficiencies in and abnormal increases of Notch signaling are also associated with human developmental anomalies and cancer, again emphasizing the importance of precisely regulating the intensity and duration of Notch signals (for reviews, see Aster et al., 2008; Bray, 2006).

The core protein components of the Notch signaling circuit are present in metazoan organisms ranging from sea urchins to humans (Fig. 1A). Canonical Notch signaling begins when a ligand of the Delta/Serrate/LAG-2 (DSL) family binds to Notch at the cell surface (Fehon et al., 1990). Ligand engagement initiates a process called regulated intramembrane proteolysis (RIP), in which the Notch receptor is first cleaved at a juxtamembrane extracellular site (S2) by a metalloprotease of the ADAM (a disintegrin and metalloprotease) family (Brou et al., 2000; Mumm et al., 2000). This ligand-dependent cleavage step renders the metalloprotease-processed, truncated receptor sensitive to subsequent intramembrane cleavage(s) at site S3 (and related sites) by the -secretase multiprotein enzyme complex (De Strooper et al., 1999; Struhl and Greenwald, 1999; Ye et al., 1999). Processing by -secretase releases the intracellular part of the Notch receptor [ICN; also known as the Notch intracellular domain (NICD)] from the membrane, allowing it to translocate into the nucleus, where it assembles into a transcriptional activation complex (Jarriault et al., 1995). The core components of this complex include the DNA-binding transcription factor CSL {C-promoter-binding factor (CBF-1 in mammals; also known as RBP-J)/Suppressor of hairless [Su(H) in Drosophila melanogaster]/LAG-1 (in Caenorhabditis elegans)} (Fortini and Artavanis-Tsakonas, 1994; Jarriault et al., 1995; Tamura et al., 1995), the ICN and a co-activator protein of the Mastermind (MAM)/LAG-3 family (Petcherski and Kimble, 2000a; Petcherski and Kimble, 2000b; Wu et al., 2000). Activation of transcription at CSL-binding sites also appears to depend on the recruitment of additional co-activators, such as p300 (E1A binding protein p300; EP300) or CREB-binding protein (CBP) (Fryer et al., 2002; Wallberg et al., 2002); these coactivators might constitute the main link between the core Notch-containing complex and the general transcription machinery.

View larger version (81K): [in this window] [in a new window]   Fig. 1. Notch signaling pathway, and domain organization of Notch receptors and DSL ligands. (A) Model for the major events in the Notch signaling pathway. Signals initiated by the engagement of ligand (1) lead to metalloprotease (MP) cleavage at site S2 (2). This proteolytic step allows the cleavage of Notch by the -secretase complex at site S3 within the transmembrane domain (3) and release of intracellular notch (ICN) from the membrane. ICN translocates to the nucleus (4), where it enters into a transcriptional activation complex with CSL and MAM, inducing the transcription of target genes (5). (B,C) The domain organization of Notch receptors (B) and DSL-family ligands (C) from fly, human and worm. TM, transmembrane domain; NEC, Notch extracellular subunit.

Because there are several recent reviews that describe the molecular events of normal and pathogenic signaling (e.g. Aster et al., 2008; Bray, 2006), here we will apply a structural and biochemical perspective to summarize progress towards understanding three central facets of canonical Notch signal transduction: (1) ligand recognition, (2) autoinhibition and the switch from protease resistance to protease sensitivity, and (3) the mechanism of nuclear-complex assembly and the induction of target-gene transcription. A summary of structures that contain components of the Notch signaling pathway and their complexes is presented in Table 1.

	Ligand recognition

Top Summary Introduction Ligand recognition Activation switch Nuclear translocation and... Conclusion and perspectives References

 
Domain organization
The N-terminal part of the Notch ectodomain consists of a series of epidermal growth factor (EGF)-like repeats that are responsible for ligand binding (Fig. 1B). Each EGF-like repeat is about 40 residues long and contains six cysteine residues that form three disulfide bonds with a characteristic pairing. The number of EGF-like repeats varies among receptors from different species. The two Notch receptors in the worm, LIN-12 and GLP-1, have 14 and 11 N-terminal EGF-like repeats, respectively, whereas the Notch receptor in the fly and the four mammalian Notch receptors are much larger, having 29-36 EGF-like repeats (Fleming, 1998).

The extracellular domains of Notch ligands of the DSL family also have a modular architecture (Fig. 1C). The N-terminal region of the ligands, with the exception of the worm proteins (which are the most divergent among the group), contains a conserved 100 residue MNNL (module at the N-terminus of Notch ligands) domain (Fig. 1C). All ligands then contain a distinct cysteine-rich module called a DSL domain near the N-terminus, followed by a series of iterated EGF-like repeats that precede the transmembrane segment. Serrate and Jagged ligands also contain a cysteine-rich domain that bears some sequence similarity to von Willebrand factor C domains between the EGF-like repeats and the transmembrane domain, whereas the Delta class of ligands does not (Fig. 1C).

Notch-ligand interactions
Early studies that investigated the binding of the fly Notch receptor to its ligands used cell-aggregation assays to detect an interaction between cells that expressed the receptor Notch and those that expressed the ligand Delta (Fehon et al., 1990). This approach was then used to show that the minimal region of Notch that is necessary and sufficient for association with Delta comprises a pair of EGF-like repeats (11 and 12) (Rebay et al., 1991). In a different assay, Irvine and colleagues constructed a series of fusions between ectodomain fragments of the fly Notch receptor and alkaline phosphatase to assess the binding of these molecules to S2 cells that expressed either the Delta or Serrate ligands (Xu et al., 2005). These studies confirmed the essential importance of EGF-like repeats 11 and 12 for binding to both ligands, and pointed out that additional repeats between 6-36 also contribute to the strength of binding in this cell-based assay. These studies also investigated the influence of modification of the Notch receptor by the N-GlcNAc transferase Fringe in modulating binding, showing that Fringe modification confers competence for the binding of Delta, but interferes with binding to Serrate. As far as the ligands are concerned, the conserved N-terminal MNNL and DSL domains both appear to participate in optimal binding to Notch (Parks et al., 2006; Shimizu et al., 1999).

We are aware of three published reports of binding assays that were performed in vitro with isolated receptor and ligand ectodomain fragments to quantify binding affinities. The Hirai group used an ELISA assay to detect the binding of soluble mouse Jagged1-Fc fusions to His-tagged mouse Notch2 ectodomain fragments that were immobilized to a surface (Shimizu et al., 1999). They determined a binding affinity of approximately 0.7 nM for the in vitro interaction between Jagged1 and an N-terminal fragment of Notch2 spanning EGF-like repeats 1-15. The Baker group also used an ELISA assay to assess interactions between secreted ectodomains of fly Notch EGF-like repeats 11-20 and Delta, estimating a dissociation constant (K_d) of 1.87 nM for this interaction from their solid-phase binding assays. Interestingly, they also detected an association between a Notch polypeptide containing EGF-like repeats 11-20 and a separate Notch fragment comprising EGF-like repeats 21-30 (Pei and Baker, 2008). This latter region overlaps with the part of Notch that contains the Abruptex class of alleles, a genetically defined, complex group of dominant Notch mutations that appear to result in enhanced Notch signaling. Finally, binding interactions between minimally interacting regions of receptor and ligand were examined by surface plasmon resonance, and a K_d of 130 M was reported for the binding of bacterially expressed, biotinylated NOTCH1 EGF-like repeats 11-14 to a Delta-like 1 (DLL1) fragment consisting of the N-terminal domain, the DSL domain and the first three EGF-like repeats. In this study, site-directed mutagenesis of a key Ca²⁺-coordinating residue in EGF-like repeat 12 was then used to show that the structural integrity of the Ca²⁺-binding site in this repeat is required for specific binding (Cordle et al., 2008b).

Despite the accruing evidence that multiple regions of both Notch receptors and ligands are involved in the binding interaction that leads to a signal, there is limited structural information available to guide a mechanistic understanding of ligand recognition. Handford and colleagues have reported nuclear magnetic resonance (NMR) and X-ray structures of a polypeptide comprising EGF-like repeats 11-13 from human NOTCH1 (Cordle et al., 2008a; Hambleton et al., 2004), and an X-ray structure of a region of JAGGED1 consisting of the DSL domain and EGF-like repeats 1-3 (Cordle et al., 2008a). In the structure of the NOTCH1 polypeptide, each EGF-like repeat adopts a characteristic EGF fold. This fold consists of a core two-stranded, antiparallel β-sheet, which is oriented parallel to the axis between its N- and C-termini, and three disulfide bonds. In the X-ray structure, the coordination of Ca²⁺ fixes the orientation between adjacent repeats, creating a gently curving, rod-like structure (Cordle et al., 2008a). By contrast, in the NMR structure, the position of EGF-like repeat 13 is less well defined with respect to repeat 12, suggesting that the interdomain relationship between EGF-like repeats 12 and 13 is more dynamic, and that the position of repeat 13 is not rigidly fixed with respect to repeat 12 (Fig. 2A). On the basis of the structure of these three Ca²⁺-binding EGF modules, the authors proposed that the ectodomain of Notch is in an extended conformation, with consecutive Ca²⁺-binding EGF-like repeats that form rigid rod-like structures, which are perhaps interrupted by non-Ca²⁺-binding repeats that impart some flexibility (Fig. 2B). To account for the results from their studies, Irvine and colleagues proposed an alternative model, in which the Notch molecule adopts a compact global conformation for optimal interaction with DSL ligands (Xu et al., 2005) (Fig. 2C). Their model postulates that the Notch ectodomain contains several potential hinge points, allowing the domain to fold onto itself to form a triple-stranded structure upon binding to ligand to afford extra avidity. The hinge points would presumably be derived from interdomain flexibility in the linkers that connect non-Ca²⁺-binding EGF-like repeats. The ability of EGF-like repeats 11-20 of the Drosophila Notch receptor to bind in trans to repeats 21-30 in solid-phase binding assays is consistent with this idea. The compact-conformation model (Fig. 2C) also rationalizes, at least in part, why there are so many EGF-like repeats in extracellular Notch, and creates a model for how variation in the glycosylation state of the receptor might modulate the affinity for different ligands by changing the flexibility of the hinges.

View larger version (36K): [in this window] [in a new window]   Fig. 2. Structures of ectodomain fragments of both NOTCH1 and JAGGED1, and models for the Notch ectodomain. (A) NMR structure of EGF-like repeats 11-13 from human NOTCH1 (PDB ID code 1TOZ). Two of the 20 calculated structures in the ensemble are shown: the double-headed arrow indicates the range of positions that are occupied by repeat 13 among the 20 calculated structures. Disulfide bonds are colored orange; hydrophobic residues engaged in interdomain contacts are shown as sticks. Bound Ca2+ ions, positioned on the basis of structural alignment with other Ca2+-binding EGF-like repeats, are shown as green spheres. (B,C) Two proposed models for the overall organization of a Notch ectodomain. In B, a rod-like, extended model is shown, whereas C illustrates one possible compact model. EGF-like repeats (ovals) are shaded dark purple when they contain a consensus Ca2+-binding site (per the definition used by UniProt) and light purple when they do not. (D) Representation of the X-ray structure for the JAGGED1 polypeptide (PDB code 2VJ2), comprising the DSL domain and EGF-like repeats 1-3. Disulfide bonds are yellow. Side-chains of residues at the proposed Notch-binding surface are rendered as colored sticks.

The X-ray structure of the JAGGED1 polypeptide (residues 187-335, corresponding to the DSL domain and the first three EGF-like repeats) represents the first glimpse of a Notch ligand at high resolution (Cordle et al., 2008a). This ligand-derived polypeptide adopts an extended structure that is reminiscent of the elongated conformation seen in EGF-like repeats 11-13 of NOTCH1 itself (Fig. 2D). The structure of the DSL domain resembles an EGF-like fold with an N-terminal extension, but the disulfide-bonding pattern is different, because one of the canonical disulfides from the EGF-like core is missing and a new disulfide bond is located within the N-terminal appendage. Accompanying pull-down experiments and functional studies that were conducted in flies support the idea that a key contribution to Notch binding is derived from conserved residues that are exposed along one face of the DSL domain (Fig. 2D), pinpointing for the first time a potential receptor-binding interface on a Notch ligand.

Unanswered questions in ligand recognition
Despite recent progress, the unresolved issue of ligand recognition means that a persistent gap remains in the current understanding of Notch signaling, and many questions are still unanswered. First, how do the receptors actually recognize ligands, and what is the stoichiometry of ligand-receptor complexes once they are formed? How much do the binding affinities vary for different ligand-receptor pairs, and how much do regions that flank the key interacting domains contribute to binding affinity and specificity? Lastly, how do post-translational glycosylation events modulate ligand recognition and signaling? The low affinity (130 M) of EGF-like repeats 11-14 for DLL1 fragments (Cordle et al., 2008b) suggests that additional EGF-like repeats might be required on the Notch-receptor side, the ligand side, or on both sides to increase avidity, as the work of Irvine and colleagues suggests. In addition, clustering of ligand or Notch receptor might be necessary to mediate adhesive interactions in a recognition synapse between communicating cells. This idea is supported by atomic-force microscopy studies that measured strong adhesion forces between cells that expressed Notch and those that expressed ligand (Ahimou et al., 2004). Once ligand-receptor complexes are formed, the next step in receptor activation relies on proteolytic release of the intracellular portion of Notch from the membrane. Thus, we next focus on how the protease resistance of Notch is maintained in the absence of ligand and how it might be released upon ligand engagement.

	Activation switch

Top Summary Introduction Ligand recognition Activation switch Nuclear translocation and... Conclusion and perspectives References

 
The negative regulatory region (NRR) of the Notch receptor, which is sandwiched between the ligand-binding and transmembrane domains (Fig. 1B), harbors the structural machinery that is necessary to maintain metalloprotease resistance in the absence of ligand. The NRR contains three cysteine-rich LIN-12–Notch repeats (LNRs) and a `heterodimerization domain' (HD), which immediately precedes the membrane and contains both the furin (S1) and metalloprotease (S2) cleavage sites. Several lines of evidence gathered over many years led to the conclusion that the NRR is the `activation switch' of the receptor. Receptors that lack the EGF-like repeats are functionally inert (Kopan et al., 1996; Lieber et al., 1993; Rebay et al., 1993; Struhl and Adachi, 1998). By contrast, deletion of the LNR modules or point mutations of key residues within them lead to gain-of-function phenotypes (Greenwald and Seydoux, 1990) and ligand-independent metalloprotease cleavage (Sanchez-Irizarry et al., 2004). The regulatory importance of the NRR is also highlighted by the fact that most NOTCH1 point mutations and insertions that are found in patients who have T-cell acute lymphocytic leukemia (T-ALL) are located within the NRR (Weng et al., 2004).

In the crystal structure of the NRR from human NOTCH2, the protein adopts an autoinhibited conformation in which an extensive interface between the LNR and HD domains buries the metalloprotease site (Gordon et al., 2007). The LNR domain covers the HD domain, much like a mushroom cap protecting its stem (Fig. 3A). Similar to the prototype LNR from human NOTCH1 that was solved by NMR (Vardar et al., 2003), each LNR module has an irregular fold with little secondary structure, and is held together by three disulfide bonds and a Ca²⁺ ion, which is coordinated by several acidic residues. The two subunits of the HD domain are intimately intertwined in an -β sandwich, and constitute a single protein domain that resembles the SEA domains of mucins (Maeda et al., 2004). The poorly conserved loop that encompasses the S1 cleavage site, which was excised to facilitate crystallization, is distant from the metalloprotease-cleavage site S2.

View larger version (102K): [in this window] [in a new window]   Fig. 3. X-ray structure of the human NOTCH2 NRR in the autoinhibited conformation and models for signal activation. (A) Ribbon representation of the NOTCH2 NRR. The LNR modules are colored different shades of pink and purple, and the HD domain is colored in white and turquoise; the white and turquoise represent residues that are N- and C-terminal, respectively, to the furin-cleavage loop (S1). The three bound Ca2+ ions are green, the bound Zn2+ ion is purple and the ten disulfide bonds are red. The positions of S1 and S2 cleavage are indicated with red arrows. (B) The LNR-AB linker sterically blocks access to the metalloprotease-cleavage site. The hydrophobic pocket in the HD domain that houses the S2 site is rendered in a surface representation, and residues from the LNR-AB linker are in ball-and-stick representation. (C) Model for activation by mechanical force. Endocytosis of bound ligand generates a mechanical force that tugs on the LNR domain (pink structure; 1), disengaging the hydrophobic plug from the hydrophobic pocket containing the S2 site (2) and peeling the LNR repeats away from the HD domain (white structure; 3). Partial or complete relaxation of the HD domain then allows access of the metalloprotease to the S2 site and cleavage of the scissile bond to trigger Notch activation (4). (D) Peeling of the LNR repeats (pink) away from the HD domain (white) might not confer sufficient exposure of the S2 site to allow cleavage by metalloprotease. The left panel depicts a hypothetical model for the negative regulatory region upon peeling of the first two LNR repeats away from the HD domain; the right panel shows the structure of the catalytic domain of the metalloprotease TACE (PDB ID code 1BKC). The deep active-site cleft is indicated. A and B are adapted from Gordon et al. (Gordon et al., 2007) and are reproduced with permission.

A key question that remains is how are the LNRs displaced to expose the S2 site? One model, first suggested by Muskavitch and colleagues to rationalize trans-endocytosis of the Notch ectodomain into ligand-expressing cells, is that bound ligand induces mechanical strain on the Notch receptor (Parks et al., 2000). In light of the NRR structure, this process can be envisioned as one in which ligand stimulation exerts a mechanical force on the Notch receptor, pulling the LNR repeats away from the HD domain to expose the S2 site (Fig. 3C). In a mechanotransduction `lift and cut' model with the NRR as the mechanosensor, endocytosis would then be the source of the mechanical force that is needed to peel the protective LNR modules away from the HD domain. This idea is consistent with the known requirement for endocytosis of ligands in Notch signal transduction, and with the finding that soluble ligands typically do not activate Notch receptors (Sun and Artavanis-Tsakonas, 1997). The alternative model for activation would be an allosteric model, in which ligand engagement trips an allosteric switch that disengages the LNR modules from the HD domain. Clearly, additional studies are needed to distinguish between these two models of activation.

In either an allosteric or mechanotransduction model for Notch activation, it is unlikely that the activating metalloproteases can gain access to the Notch S2 site after mere stripping of the LNR modules away from the HD domain, because the active sites of metalloproteases, such as tumor-necrosis factor (TNF)-converting enzyme (TACE, also known as ADAM17) lie in a deep cleft (Fig. 3D). Thus, we would expect that certain key secondary structural elements of the HD domain also unravel after displacement of the LNR repeats, generating an `open' conformation that renders the S2 site accessible to the protease. Such conformational changes in the HD domain might include localized movement or melting of helix3, which is anchored above the cleavage site (Fig. 3B), to release the strand that contains the S2 site, or might even cause complete unfolding of the HD domain with accompanying subunit dissociation (Nichols et al., 2007).

The discovery that mutations are frequently found in the HD domain of NOTCH1 in human T-ALL patients moved NOTCH1 to the forefront in understanding disease pathogenesis and also pointed to the NOTCH1 NRR as a mechanism-based therapeutic target. These mutations, which map primarily to the highly conserved hydrophobic interior of the HD, lead to ligand-independent increases in signaling, suggesting that domain destabilization facilitates ligand-independent S2 cleavage and subsequent receptor activation (Malecki et al., 2006; Weng et al., 2004). Recently, inhibitory and activating antibodies against the NRR from human NOTCH3 were reported (Li et al., 2008) – the epitope of the inhibitory antibody includes residues from both the LNR-A and HD domains, consistent with the notion that it clamps the NRR in its metalloprotease-resistant conformation. Importantly, the existence of modulatory antibodies constitutes proof of principle, showing that it is possible to identify mechanism-based therapeutics that turn Notch signaling on or off via the NRR. Additional studies to define the structural characteristics of the `on' state of the NRR in normal and disease-associated signaling should also help to guide the development of mechanism-based modulators of signaling.

	Nuclear translocation and transcriptional regulation

Top Summary Introduction Ligand recognition Activation switch Nuclear translocation and... Conclusion and perspectives References

 
The ICN, which is released from the membrane upon -secretase cleavage, is a potent inducer of target-gene transcription. In canonical Notch signaling, transcriptional activation depends on the formation of a core protein-DNA complex that includes the ICN, the CSL transcription factor and a protein of the MAM family [MAM-like (MAML) in mammals].

The ICN comprises several functional regions, including an N-terminal RAM (recombination binding protein-J -associated molecule) domain (Tamura et al., 1995), an ankyrin (ANK) domain and less-conserved regions, including a variable transactivation domain (Kurooka et al., 1998) and a C-terminal PEST sequence (Fig. 1A). The ANK domain, which comprises seven ANK repeats, is the most conserved region of the ICN and is essential for Notch-receptor function. Each ANK repeat is about 33 residues long and typically folds into a pair of antiparallel helices followed by a β-hairpin that connects to the next repeat; together, the repeats stack to form a curved, elongated domain (Mosavi et al., 2004). In X-ray structures of isolated ANK domains from the fly Notch receptor and human NOTCH1, ANK repeats 2-7 are ordered, whereas the first repeat remains disordered (Ehebauer et al., 2005; Nam et al., 2006; Zweifel et al., 2003).

The structure of worm CSL (LAG-1), bound to a 13-mer DNA duplex corresponding to a CSL-binding site in the proximal promoter of the hes1 gene (a well-characterized human target of activated Notch), revealed an unpredicted domain organization for CSL (Kovall and Hendrickson, 2004). The structured core of CSL consists of three domains: an N-terminal Rel-homology region (RHR-N), a central β-trefoil domain (BTD) and a C-terminal Rel-homology region (RHR-C). A long β-strand extends from the BTD to the RHR-C, connecting all three domains such that RHR-C sits atop the RHR-N. The DNA is bound by the BTD and the RHR-N and makes no contacts with the distal RHR-C domain. A large surface is buried at the protein-DNA interface, with extensive non-specific contacts between the highly conserved and basic CSL face and the phosphate backbone, and base-specific contacts with six of the eight base pairs of the core CSL-binding consensus.

View larger version (139K): [in this window] [in a new window]   Fig. 4. Ribbon diagrams representing the structure of human and worm Notch ternary complexes. (A, left) Human complex of the ANK domain of NOTCH1 (blue), CSL (green) and the N-terminal region of MAML1 (red) bound to an 18 base-pair DNA sequence from the hes1 promoter (PDB code 2F8X). (A, right) Worm complex of the RAMANK region of LIN-12 (ANK and RAM are blue and cyan, respectively), LAG-1 (green), and the N-terminal region of SEL-8 (red) (PDB code 2FO1). The structures illustrate the cooperative binding of MAM to a composite surface that is created at the interface between the Notch ANK domain and CSL. Bottom panels show a 105° rotation around the vertical axis. (B) Superposition of CSL structures, showing the difference in loop conformation between CSL-DNA complexes and complexes that include RAM domains, ANK domains or both. Mouse CSL-DNA (PDB code 3BRG, magenta) and worm CSL-DNA (PDB code 1TTU, green) structures have a `closed' loop. Worm RAM-CSL-DNA (PDB code 3BRF, yellow; PDB code 3BRD, cyan), human ANK-MAM-CSL-DNA (red) and worm RAMANK-MAM-CSL-DNA (blue) complexes have an `open' loop. (C) Superposition of worm (bright) and human (faded) ternary-complex structures. Several unique insertions at the N-terminus of RAM and within the ANK domain are found in worm LIN-12 but not in other Notch molecules (orange). These features might play a role in the more compact packing of the worm NTC structure when compared with the human NTC structure.

Insights from structures of Notch transcription complexes
X-ray crystal structures of human and worm Notch transcription complexes (NTCs), which include portions of intracellular Notch, CSL and MAM bound to DNA, provide the structural basis for cooperativity in the recruitment of MAM to NTCs (Nam et al., 2006; Wilson and Kovall, 2006). In both the human and worm complexes, the concave face of the Notch ANK domain packs against the two RHR domains of CSL, with most of the contact interface derived from RHR-C. The MAM polypeptide, which is disordered in solution in the case of human MAML1 (Nam et al., 2006), adopts a helical conformation in both complexes, and makes extensive contacts with a composite surface that is derived from the interface between the ANK and RHR-C domains. A kink in the MAM helix also allows it to wrap further around CSL to contact the RHR-N domain in both cases (Fig. 4A).

In several studies of isolated Notch ANK domains, the first ANK repeat does not adopt a typical ANK fold, and is at least partially disordered (Ehebauer et al., 2005; Nam et al., 2006; Zweifel et al., 2003). However, this first repeat is ordered in both the human (Nam et al., 2006) and worm (Wilson and Kovall, 2006) NTC structures. The worm NTC structure, which includes both RAM and ANK regions, also has electron density from two short parts of the N- and C-termini of RAM, but the remainder of RAM is not visible in the structure, an observation that is consistent with disorder in the intervening region. A 20-residue sequence at the N-terminus of RAM, which includes a conserved WxP motif that has been implicated in the binding of RAM to the BTD of CSL in previous studies, binds to a groove in the BTD of CSL at a site that is distant from the CSL interface with the ANK domain and MAM. The C-terminal part of the RAM region adopts an ANK-like fold, which caps the N-terminus of the ANK domain and might help to stabilize the first ANK repeat in the complex. Similar to MAM and the first ANK repeat of Notch, the N-terminal cap also appears to become ordered only upon complex formation.

When the CSL-DNA and ternary complexes from worm are directly compared, it is evident that CSL adopts a more closed conformation in the complex with RAMANK (constructs of Notch that encompass both the RAM and ANK domains) and MAM than it does alone (Kovall and Hendrickson, 2004; Wilson and Kovall, 2006). Areas of the RHR-N and BTD that are near the DNA interface superimpose well, but the RHR-C and parts of the BTD of CSL in the ternary complex are closer to each other, filling more of the cavity in the U-shaped CSL molecule. By contrast, the CSL molecule in the human NTC complex, which only includes the ANK domain of Notch, remains in a more open conformation that more closely resembles that of the worm CSL-DNA complex.

Role of the RAM region in transcription-complex assembly
It has been speculated that this difference between the human and worm ternary complexes was due to the binding of the N-terminal RAM peptide in the worm structure, which was not present in the human structure (Barrick and Kopan, 2006). Alternatively, the conformational differences between the complexes could also be accounted for by species-specific differences in the RAM and ANK regions of the various proteins, or by intrinsic flexibility of the CSL protein (Fig. 4). Three recently reported structures, including two worm CSL-RAM-DNA complexes in different crystallographic space groups and a mouse CSL-DNA complex, further clarify the influence of RAM on the conformation of CSL (Friedmann et al., 2008). A significant finding from these studies is that the RAM region does not induce global closure of CSL upon binding, indicating that the primary structural differences between the two ternary complexes are a consequence of interspecies variation or conformational flexibility.

One consistent conformational difference noted among different classes of CSL-containing structures is in the position of a loop (connecting strands C and C') of the RHR-N domain of CSL; this loop is located directly below the C-terminal portion of MAM (Friedmann et al., 2008). In all structures that contain either the ANK or RAM domain (or both domains, as in the case of the worm ternary complex), this loop is in an `open' conformation, with the loop flipped away from MAM, whereas the loop is in a `closed' conformation in the two CSL-DNA structures that were solved in isolation from worm and mouse (Fig. 4B). Because a side chain from the loop would clash with one of the MAM side chains when the loop is in the closed position, the authors propose that the binding of RAM to the BTD of CSL might trigger opening of the loop in the RHR-N domain, but this possibility has not yet been tested directly. Examination of the structures suggests that a simple side-chain rotation around the β-carbon atom of the loop residue might prevent the clash, but perhaps a movement of the entire loop is the most energetically favored way to accommodate MAM.

Recent biochemical studies, which complement these crystal structures, suggest that the primary role of the RAM region is to recruit intracellular Notch to CSL. Biophysical studies of the complete RAM region in isolation and in the context of RAM-ANK polypeptides have shown that RAM is natively unstructured (Nam et al., 2003). In addition, the 70 residues linking the part of RAM bound to the β-trefoil domain of CSL and the N-terminal cap of the ANK domain remains disordered in the worm transcription complex (Wilson and Kovall, 2006). Modeling of the unstructured region between the bound RAM peptide and the N-terminal end of the ANK domain as a worm-like chain reveals that the most probable distance between the two CSL-binding domains is about 50 Å (Bertagna et al., 2008), which is in very good agreement with the distance between the binding sites in the ternary-complex structures. The affinity of RAM peptides for various CSL proteins from different species, which has been determined in several different studies (Del Bianco et al., 2008; Friedmann et al., 2008; Lubman et al., 2007), ranges from 0.022 to 2 M. By contrast, the affinity of the ANK domain for CSL is low (Nam et al., 2003), and has been estimated to be greater than 20 M (Del Bianco et al., 2008). Above the concentrations that are needed for saturated binding of RAM peptide to CSL, the worm-like-chain approximation predicts an effective concentration for the ANK domain of around 0.5 mM (Bertagna et al., 2008), which is consistent with fluorescence-transfer experiments suggesting that recruitment via RAM leads to docking of the ANK domain onto its cognate site on CSL (Del Bianco et al., 2008). Together, the structural and biochemical studies best support a model for complex assembly in which the high-affinity RAM peptide interacts first with its binding site on CSL, increasing the effective local concentration of the ANK domain and allowing this domain to nestle onto the RHR part of CSL to create the composite interface for MAM recruitment.

Despite the structural and biochemical information that is now accumulating about the RAM and ANK domains of intracellular Notch, less is known about the overall structure of the entire ICN molecule that is released from the membrane upon -secretase cleavage. Recent single-particle electron-microscopy analysis of ICN from the fly indicates that intact ICN can adopt either an extended or a compact conformation (Kelly et al., 2007). At low ionic strength, the compact form is favored, whereas increasing Ca²⁺ concentrations induce a shift from a compact ICN form that cannot bind CSL to an extended form that binds CSL, and ultimately to a fibrous aggregated form that can no longer bind CSL (Kelly et al., 2007). Together, the biochemistry and electron-microscopy data suggest that modulation of the conformation of ICN regulates its activity. However, given that the Ca²⁺ concentrations used in these studies are unlikely to be physiological, the triggers that might be responsible for such conformational rearrangements remain unknown.

Formation of higher-order complexes on specialized promoter elements
A remaining challenge in understanding how ICN acts as an accessory transcription factor is to elucidate the transcriptional codes that constitute Notch response elements in different biological signaling contexts. One small step in that direction emerged from the consideration of the packing arrangement of symmetry-related complexes in the structure of the human NTC on an 18-mer CSL consensus binding site from the hes1 promoter region (Nam et al., 2007; Nam et al., 2006). In a number of well-characterized Notch-responsive genes in flies and mammals, including hes1 (Hairy and enhancer of split 1), the proximal promoter contains dual Su(H)-paired sites or `sequence-paired' binding sites (SPSs). These elements consist of two CSL-binding sites that are oriented head to head and that are typically separated by 16 or 17 nucleotides (Bailey and Posakony, 1995; Nellesen et al., 1999). Previous studies of genes containing SPS elements have shown that the integrity of the SPS is needed for proper Notch-dependent gene transcription in cell-based assays and transgenic flies (Cave et al., 2005; Ong et al., 2006).

In the structure of the human NTC, crystal contacts between two copies of the ANK domain that are related by a two-fold symmetry axis orient the two 18-mer hes1 DNA duplexes in a near-linear orientation that mimics an inverted-repeat pair of sites. In the crystal lattice, the two CSL-binding sites are about 65 Å apart, corresponding approximately to the distance spanned by 19 base pairs of B-form DNA (Fig. 5). Biochemical studies revealed that residues that are engaged in these crystal contacts help to guide cooperative dimerization of NTCs on the SPS from the hes1-promoter region and that disruption of the putative dimer interface within the ANK domain prevents the induction of a luciferase reporter gene under the control of the same promoter region (Nam et al., 2007). The existence of clustered CSL sites in many other Notch-responsive genes also raises the possibility that the assembly of higher-order Notch complexes might represent a more general mechanism for regulating target-gene transcription. Taken together with the structural and biochemical studies of complexes that are assembled on single sites, the potential for dimerization of NTCs leads to a new working model for the assembly of various Notch nuclear complexes (Fig. 6).

View larger version (36K): [in this window] [in a new window]   Fig. 5. Ribbon diagram of two symmetry-related copies of the human NTC (PDB code 2F8X), revealing the near-linear orientation of the two DNA elements, which mimics the inverted repeat of the SPS element. Superposition of the symmetry-related pseudo-dimer (DNA in yellow, with CSL-binding sites in orange) on ideal B-form DNA corresponding to 42 base pairs of the hes1 promoter (gray, with CSL-binding sites in black) reveals that the orientation and spacing between the two CSL sites in the crystal approximates, but does not match, the expected spacing and orientation in a natural SPS.

View larger version (33K): [in this window] [in a new window]   Fig. 6. Model for the assembly of Notch ternary complexes. A high-affinity interaction between the N-terminal RAM peptide of Notch and the BTD of CSL is likely to be the first event in the assembly of Notch transcriptional activation complexes. This step allows the lower-affinity ANK domain to bind at its docking site, resulting in ordering of the ankyrin-like N-cap and first repeat of the ANK domain. The interface between the ANK domain and the RHR-N (N) and RHR-C (C) domains of CSL create a composite surface for the binding of MAM, which recruits p300 or CBP. Higher-order homotypic assemblies of Notch complexes or heterotypic assemblies with other transcription factors might be required for the transcription of specific Notch targets.

	Conclusion and perspectives

Top Summary Introduction Ligand recognition Activation switch Nuclear translocation and... Conclusion and perspectives References

 
A number of significant structural and biochemical advances over the past several years have enhanced the current understanding of the molecular logic of Notch signaling, but the picture is by no means complete. There are representative structures of a ligand-binding fragment of human NOTCH1 and of a minimal Notch-binding fragment of human JAGGED1, yet the three-dimensional organizations of the complete Notch and ligand ectodomains remain unknown, as does the structural basis for ligand recognition. Similarly, the X-ray structure of the activation switch of human NOTCH2 has revealed the molecular basis for autoinhibition, but a clear picture of how ligand stimulation relieves this autoinhibition has yet to emerge.

With regards to Notch transcription complexes, structural and biochemical studies of the core assemblies from human and worm provide substantial insight into how ICN and CSL combine to recruit MAM proteins. However, eukaryotic gene transcription usually requires the concerted binding of multiple DNA-binding transcription factors, and Notch-responsive genes are no exception. Understanding the structural basis for cooperativity between the Notch transcription complex and other DNA-binding transcription factors is likely to be one future research frontier. Another might be how the core transcription complexes engage other key transcriptional regulators, such as histone acetyl transferases and chromatin-remodeling complexes, to activate gene transcription. Deciphering the additional complexity that results from post-translational modifications, such as phosphorylation and hydroxylation, represents yet another future challenge. These problems, along with other unresolved issues in the biochemistry and signaling of the Notch pathway, should keep researchers busy for several years to come.

	References

Top Summary Introduction Ligand recognition Activation switch Nuclear translocation and... Conclusion and perspectives References

 

Acar, M., Jafar-Nejad, H., Takeuchi, H., Rajan, A., Ibrani, D., Rana, N. A., Pan, H., Haltiwanger, R. S. and Bellen, H. J. (2008). Rumi is a CAP10 domain glycosyltransferase that modifies Notch and is required for Notch signaling. Cell 132, 247-258.[CrossRef][Medline]

Ahimou, F., Mok, L. P., Bardot, B. and Wesley, C. (2004). The adhesion force of Notch with Delta and the rate of Notch signaling. J. Cell Biol. 167, 1217-1229.[Abstract/Free Full Text]

Aster, J. C., Robertson, E. S., Hasserjian, R. P., Turner, J. R., Kieff, E. and Sklar, J. (1997). Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription. J. Biol. Chem. 272, 11336-11343.[Abstract/Free Full Text]

Aster, J. C., Pear, W. S. and Blacklow, S. C. (2008). Notch signaling in leukemia. Annu. Rev. Pathol. 3, 587-613.[CrossRef][Medline]

Bailey, A. M. and Posakony, J. W. (1995). Suppressor of hairless directly activates transcription of enhancer of split complex genes in response to Notch receptor activity. Genes Dev. 9, 2609-2622.[Abstract/Free Full Text]

Barrick, D. and Kopan, R. (2006). The Notch transcription activation complex makes its move. Cell 124, 883-885.[CrossRef][Medline]

Bertagna, A., Toptygin, D., Brand, L. and Barrick, D. (2008). The effects of conformational heterogeneity on the binding of the Notch intracellular domain to effector proteins: a case of biologically tuned disorder. Biochem. Soc. Trans. 36, 157-166.[CrossRef][Medline]

Bray, S. J. (2006). Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell. Biol. 7, 678-689.[CrossRef][Medline]

Brou, C., Logeat, F., Gupta, N., Bessia, C., LeBail, O., Doedens, J. R., Cumano, A., Roux, P., Black, R. A. and Israel, A. (2000). A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell 5, 207-216.[CrossRef][Medline]

Bruckner, K., Perez, L., Clausen, H. and Cohen, S. (2000). Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature 406, 411-415.[CrossRef][Medline]

Busseau, I., Diederich, R. J., Xu, T. and Artavanis-Tsakonas, S. (1994). A member of the Notch group of interacting loci, deltex encodes a cytoplasmic basic protein. Genetics 136, 585-596.[Abstract]

Cave, J. W., Loh, F., Surpris, J. W., Xia, L. and Caudy, M. A. (2005). A DNA transcription code for cell-specific gene activation by notch signaling. Curr. Biol. 15, 94-104.[CrossRef][Medline]

Cohen, B., Bashirullah, A., Dagnino, L., Campbell, C., Fisher, W. W., Leow, C. C., Whiting, E., Ryan, D., Zinyk, D., Boulianne, G. et al. (1997). Fringe boundaries coincide with Notch-dependent patterning centres in mammals and alter Notch-dependent development in Drosophila. Nat. Genet. 16, 283-288.[CrossRef][Medline]

Coleman, M. L., McDonough, M. A., Hewitson, K. S., Coles, C., Mecinovic, J., Edelmann, M., Cook, K. M., Cockman, M. E., Lancaster, D. E., Kessler, B. M. et al. (2007). Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J. Biol. Chem. 282, 24027-24038.[Abstract/Free Full Text]

Cordle, J., Johnson, S., Zi Yan Tay, J., Roversi, P., Wilkin, M. B., de Madrid, B. H., Shimizu, H., Jensen, S., Whiteman, P., Jin, B. et al. (2008a). A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition. Nat. Struct. Mol. Biol. 15, 849-857.[CrossRef][Medline]

Cordle, J., Redfieldz, C., Stacey, M., van der Merwe, P. A., Willis, A. C., Champion, B. R., Hambleton, S. and Handford, P. A. (2008b). Localization of the Delta-like-1-binding Site in Human Notch-1 and Its Modulation by Calcium Affinity. J. Biol. Chem. 283, 11785-11793.[Abstract/Free Full Text]

De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. S., Schroeter, E. H., Schrijvers, V., Wolfe, M. S., Ray, W. J. et al. (1999). A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518-522.[CrossRef][Medline]

Deblandre, G. A., Lai, E. C. and Kintner, C. (2001). Xenopus neuralized is a ubiquitin ligase that interacts with XDelta1 and regulates Notch signaling. Dev. Cell 1, 795-806.[CrossRef][Medline]

Del Bianco, C., Aster, J. C. and Blacklow, S. C. (2008). Mutational and energetic studies of Notch 1 transcription complexes. J. Mol. Biol. 376, 131-140.[CrossRef][Medline]

Diederich, R. J., Matsuno, K., Hing, H. and Artavanis-Tsakonas, S. (1994). Cytosolic interaction between deltex and Notch ankyrin repeats implicates deltex in the Notch signaling pathway. Development 120, 473-481.[Abstract]

Ehebauer, M. T., Chirgadze, D. Y., Hayward, P., Martinez Arias, A. and Blundell, T. L. (2005). High-resolution crystal structure of the human Notch 1 ankyrin domain. Biochem. J. 392, 13-20.[CrossRef][Medline]

Fedoroff, O. Y., Townson, S. A., Golovanov, A. P., Baron, M. and Avis, J. M. (2004). The structure and dynamics of tandem WW domains in a negative regulator of notch signaling, Suppressor of deltex. J. Biol. Chem. 279, 34991-35000.[Abstract/Free Full Text]

Fehon, R. G., Kooh, P. J., Rebay, I., Regan, C. L., Xu, T., Muskavitch, M. A. and Artavanis-Tsakonas, S. (1990). Molecular interactions between the protein products of the neurogenic loci Notch and Delta, two EGF-homologous genes in Drosophila. Cell 61, 523-534.[CrossRef][Medline]

Fleming, R. J. (1998). Structural conservation of Notch receptors and ligands. Semin. Cell Dev. Biol. 9, 599-607.[CrossRef][Medline]

Fortini, M. E. and Artavanis-Tsakonas, S. (1994). The suppressor of hairless protein participates in notch receptor signaling. Cell 79, 273-282.[CrossRef][Medline]

Friedmann, D. R., Wilson, J. J. and Kovall, R. A. (2008). RAM induced allostery facilitates assembly of a notch pathway active transcription complex. J. Biol. Chem. 283, 14781-14791.[Abstract/Free Full Text]

Fryer, C. J., Lamar, E., Turbachova, I., Kintner, C. and Jones, K. A. (2002). Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. Genes Dev. 16, 1397-1411.[Abstract/Free Full Text]

Gordon, W. R., Vardar-Ulu, D., Histen, G., Sanchez-Irizarry, C., Aster, J. C. and Blacklow, S. C. (2007). Structural basis for autoinhibition of Notch. Nat. Struct. Mol. Biol. 14, 295-300.[CrossRef][Medline]

Greenwald, I. and Seydoux, G. (1990). Analysis of gain-of-function mutations of the lin-12 gene of Caenorhabditis elegans. Nature 346, 197-199.[CrossRef][Medline]

Gupta-Rossi, N., Le Bail, O., Gonen, H., Brou, C., Logeat, F., Six, E., Ciechanover, A. and Israel, A. (2001). Functional Interaction between SEL-10, an F-box Protein, and the Nuclear Form of Activated Notch1 Receptor. J. Biol. Chem. 276, 34371-34378.[Abstract/Free Full Text]

Hambleton, S., Valeyev, N. V., Muranyi, A., Knott, V., Werner, J. M., McMichael, A. J., Handford, P. A. and Downing, A. K. (2004). Structural and functional properties of the human notch-1 ligand binding region. Structure 12, 2173-2183.[Medline]

Hao, B., Oehlmann, S., Sowa, M. E., Harper, J. W. and Pavletich, N. P. (2007). Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol. Cell 26, 131-143.[CrossRef][Medline]

Hubbard, E. J., Wu, G., Kitajewski, J. and Greenwald, I. (1997). sel-10, a negative regulator of lin-12 activity in Caenorhabditis elegans, encodes a member of the CDC4 family of proteins. Genes Dev. 11, 3182-3193.[Abstract/Free Full Text]

Itoh, M., Kim, C. H., Palardy, G., Oda, T., Jiang, Y. J., Maust, D., Yeo, S. Y., Lorick, K., Wright, G. J., Ariza-McNaughton, L. et al. (2003). Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev. Cell 4, 67-82.[CrossRef][Medline]

Jarriault, S., Brou, C., Logeat, F., Schroeter, E. H., Kopan, R. and Israel, A. (1995). Signalling downstream of activated mammalian Notch. Nature 377, 355-358.[CrossRef][Medline]

Jennings, M. D., Blankley, R. T., Baron, M., Golovanov, A. P. and Avis, J. M. (2007). Specificity and autoregulation of Notch binding by tandem WW domains in suppressor of Deltex. J. Biol. Chem. 282, 29032-29042.[Abstract/Free Full Text]

Jinek, M., Chen, Y. W., Clausen, H., Cohen, S. M. and Conti, E. (2006). Structural insights into the Notch-modifying glycosyltransferase Fringe. Nat. Struct. Mol. Biol. 13, 945-946.[CrossRef][Medline]

Johnston, S. H., Rauskolb, C., Wilson, R., Prabhakaran, B., Irvine, K. D. and Vogt, T. F. (1997). A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. Development 124, 2245-2254.[Abstract]

Kelly, D. F., Lake, R. J., Walz, T. and Artavanis-Tsakonas, S. (2007). Conformational variability of the intracellular domain of Drosophila Notch and its interaction with Suppressor of Hairless. Proc. Natl. Acad. Sci. USA 104, 9591-9596.[Abstract/Free Full Text]

Kopan, R., Schroeter, E. H., Weintraub, H. and Nye, J. S. (1996). Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc. Natl. Acad. Sci. USA 93, 1683-1688.[Abstract/Free Full Text]

Kovall, R. A. and Hendrickson, W. A. (2004). Crystal structure of the nuclear effector of Notch signaling, CSL, bound to DNA. EMBO J. 23, 3441-3451.[CrossRef][Medline]

Kurooka, H., Kuroda, K. and Honjo, T. (1998). Roles of the ankyrin repeats and C-terminal region of the mouse notch1 intracellular region [published erratum appears in Nucleic Acids Res. 1999 Mar 1;27(5):following 1407]. Nucleic Acids Res. 26, 5448-5455.[Abstract/Free Full Text]

Lai, E. C., Deblandre, G. A., Kintner, C. and Rubin, G. M. (2001). Drosophila neuralized is a ubiquitin ligase that promotes the internalization and degradation of delta. Dev. Cell 1, 783-794.[CrossRef][Medline]

Lai, E. C., Roegiers, F., Qin, X., Jan, Y. N. and Rubin, G. M. (2005). The ubiquitin ligase Drosophila Mind bomb promotes Notch signaling by regulating the localization and activity of Serrate and Delta. Development 132, 2319-2332.[Abstract/Free Full Text]

Lazarov, V. K., Fraering, P. C., Ye, W., Wolfe, M. S., Selkoe, D. J. and Li, H. (2006). Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores. Proc. Natl. Acad. Sci. USA 103, 6889-6894.[Abstract/Free Full Text]

Le Borgne, R., Bardin, A. and Schweisguth, F. (2005a). The roles of receptor and ligand endocytosis in regulating Notch signaling. Development 132, 1751-1762.[Abstract/Free Full Text]

Le Borgne, R., Remaud, S., Hamel, S. and Schweisguth, F. (2005b). Two distinct E3 ubiquitin ligases have complementary functions in the regulation of delta and serrate signaling in Drosophila. PLoS Biol. 3, e96.[CrossRef][Medline]

Li, K., Li, Y., Wu, W., Gordon, W. R., Chang, D. W., Lu, M., Scoggin, S., Fu, T., Vien, L., Histen, G. et al. (2008). Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3. J. Biol. Chem. 283, 8046-8054.[Abstract/Free Full Text]

Lieber, T., Kidd, S., Alcamo, E., Corbin, V. and Young, M. W. (1993). Antineurogenic phenotypes induced by truncated Notch proteins indicate a role in signal transduction and may point to a novel function for Notch in nuclei. Genes Dev. 7, 1949-1965.[Abstract/Free Full Text]

Lubman, O. Y., Kopan, R., Waksman, G. and Korolev, S. (2005). The crystal structure of a partial mouse Notch-1 ankyrin domain: repeats 4 through 7 preserve an ankyrin fold. Protein Sci. 14, 1274-1281.[CrossRef][Medline]

Lubman, O. Y., Ilagan, M. X., Kopan, R. and Barrick, D. (2007). Quantitative dissection of the Notch:CSL interaction: insights into the Notch-mediated transcriptional switch. J. Mol. Biol. 365, 577-589.[CrossRef][Medline]

Maeda, T., Inoue, M., Koshiba, S., Yabuki, T., Aoki, M., Nunokawa, E., Seki, E., Matsuda, T., Motoda, Y., Kobayashi, A. et al. (2004). Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125 (MUC16). J. Biol. Chem. 279, 13174-13182.[Abstract/Free Full Text]

Malecki, M. J., Sanchez-Irizarry, C., Mitchell, J. L., Histen, G., Xu, M. L., Aster, J. C. and Blacklow, S. C. (2006). Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol. Cell. Biol. 26, 4642-4651.[Abstract/Free Full Text]

Mao, J. H., Perez-Losada, J., Wu, D., Delrosario, R., Tsunematsu, R., Nakayama, K. I., Brown, K., Bryson, S. and Balmain, A. (2004). Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 432, 775-779.[CrossRef][Medline]

Maskos, K., Fernandez-Catalan, C., Huber, R., Bourenkov, G. P., Bartunik, H., Ellestad, G. A., Reddy, P., Wolfson, M. F., Rauch, C. T., Castner, B. J. et al. (1998). Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc. Natl. Acad. Sci. USA 95, 3408-3412.[Abstract/Free Full Text]

Matsuno, K., Diederich, R. J., Go, M. J., Blaumueller, C. M. and Artavanis-Tsakonas, S. (1995). Deltex acts as a positive regulator of Notch signaling through interactions with the Notch ankyrin repeats. Development 121, 2633-2644.[Abstract]

Matsuno, K., Eastman, D., Mitsiades, T., Quinn, A. M., Carcanciu, M. L., Ordentlich, P., Kadesch, T. and Artavanis-Tsakonas, S. (1998). Human deltex is a conserved regulator of Notch signalling. Nat. Genet. 19, 74-78.[CrossRef][Medline]

Miyamoto, K., Muto, Y., Tochio, N., Koshiba, S., Inoue, M., Yabuki, T., Aoki, M., Tomo, Y. and Seki, E. (2004). Solution structure of the RING-H2 finger domain of mouse Deltex protein 2. Nippon Bunshi Seibutsu Gakkai Nenkai Puroguramu, Koen Yoshishu 27, 815.

Moloney, D. J., Panin, V. M., Johnston, S. H., Chen, J., Shao, L., Wilson, R., Wang, Y., Stanley, P., Irvine, K. D., Haltiwanger, R. S. et al. (2000). Fringe is a glycosyltransferase that modifies Notch. Nature 406, 369-375.[CrossRef][Medline]

Mosavi, L. K., Cammett, T. J., Desrosiers, D. C. and Peng, Z. Y. (2004). The ankyrin repeat as molecular architecture for protein recognition. Protein Sci. 13, 1435-1448.[CrossRef][Medline]

Mukherjee, A., Veraksa, A., Bauer, A., Rosse, C., Camonis, J. and Artavanis-Tsakonas, S. (2005). Regulation of Notch signalling by non-visual beta-arrestin. Nat. Cell Biol. 7, 1191-1201.[Medline]

Mumm, J. S., Schroeter, E. H., Saxena, M. T., Griesemer, A., Tian, X., Pan, D. J., Ray, W. J. and Kopan, R. (2000). A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol. Cell 5, 197-206.[CrossRef][Medline]

Nam, Y., Weng, A. P., Aster, J. C. and Blacklow, S. C. (2003). Structural requirements for assembly of the CSL.intracellular Notch1.Mastermind-like 1 transcriptional activation complex. J. Biol. Chem. 278, 21232-21239.[Abstract/Free Full Text]

Nam, Y., Sliz, P., Song, L., Aster, J. C. and Blacklow, S. C. (2006). Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes. Cell 124, 973-983.[CrossRef][Medline]

Nam, Y., Sliz, P., Pear, W. S., Aster, J. C. and Blacklow, S. C. (2007). Cooperative assembly of higher-order Notch complexes functions as a switch to induce transcription. Proc. Natl. Acad. Sci. USA 104, 2103-2108.[Abstract/Free Full Text]

Nellesen, D. T., Lai, E. C. and Posakony, J. W. (1999). Discrete enhancer elements mediate selective responsiveness of enhancer of split complex genes to common transcriptional activators. Dev. Biol. 213, 33-53.[CrossRef][Medline]

Nichols, J. T., Miyamoto, A., Olsen, S. L., D'Souza, B., Yao, C. and Weinmaster, G. (2007). DSL ligand endocytosis physically dissociates Notch1 heterodimers before activating proteolysis can occur. J. Cell Biol. 176, 445-458.[Abstract/Free Full Text]

Oberg, C., Li, J., Pauley, A., Wolf, E., Gurney, M. and Lendahl, U. (2001). The notch intracellular domain is ubiquitinated and negatively regulated by the mammalian sel-10 homolog. J. Biol. Chem. 276, 35847-35853.[Abstract/Free Full Text]

Ogura, T., Mio, K., Hayashi, I., Miyashita, H., Fukuda, R., Kopan, R., Kodama, T., Hamakubo, T., Iwatsubo, T., Tomita, T. et al. (2006). Three-dimensional structure of the gamma-secretase complex. Biochem. Biophys. Res. Commun. 343, 525-534.[CrossRef][Medline]

Ong, C. T., Cheng, H. T., Chang, L. W., Ohtsuka, T., Kageyama, R., Stormo, G. D. and Kopan, R. (2006). Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and CSL-binding site architecture determines activation probability. J. Biol. Chem. 281, 5106-5119.[Abstract/Free Full Text]

Overstreet, E., Fitch, E. and Fischer, J. A. (2004). Fat facets and Liquid facets promote Delta endocytosis and Delta signaling in the signaling cells. Development 131, 5355-5366.[Abstract/Free Full Text]

Panin, V. M., Papayannopoulos, V., Wilson, R. and Irvine, K. D. (1997). Fringe modulates Notch-ligand interactions. Nature 387, 908-912.[CrossRef][Medline]

Parks, A. L., Klueg, K. M., Stout, J. R. and Muskavitch, M. A. (2000). Ligand endocytosis drives receptor dissociation and activation in the Notch pathway. Development 127, 1373-1385.[Abstract]

Parks, A. L., Stout, J. R., Shepard, S. B., Klueg, K. M., Dos Santos, A. A., Parody, T. R., Vaskova, M. and Muskavitch, M. A. (2006). Structure-function analysis of delta trafficking, receptor binding and signaling in Drosophila. Genetics 174, 1947-1961.[Abstract/Free Full Text]

Pavlopoulos, E., Pitsouli, C., Klueg, K. M., Muskavitch, M. A., Moschonas, N. K. and Delidakis, C. (2001). neuralized Encodes a peripheral membrane protein involved in delta signaling and endocytosis. Dev. Cell 1, 807-816.[CrossRef][Medline]

Pei, Z. and Baker, N. E. (2008). Competition between Delta and the Abruptex domain of Notch. BMC Dev. Biol. 8, 4.[CrossRef][Medline]

Petcherski, A. G. and Kimble, J. (2000a). LAG-3 is a putative transcriptional activator in the C. elegans Notch pathway. Nature 405, 364-368.[CrossRef][Medline]

Petcherski, A. G. and Kimble, J. (2000b). Mastermind is a putative activator for Notch. Curr. Biol. 10, R471-R473.[CrossRef][Medline]

Rebay, I., Fleming, R. J., Fehon, R. G., Cherbas, L., Cherbas, P. and Artavanis-Tsakonas, S. (1991). Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. Cell 67, 687-699.[CrossRef][Medline]

Rebay, I., Fehon, R. G. and Artavanis-Tsakonas, S. (1993). Specific truncations of Drosophila Notch define dominant activated and dominant negative forms of the receptor. Cell 74, 319-329.[CrossRef][Medline]

Sanchez-Irizarry, C., Carpenter, A. C., Weng, A. P., Pear, W. S., Aster, J. C. and Blacklow, S. C. (2004). Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol. Cell. Biol. 24, 9265-9273.[Abstract/Free Full Text]

Shimizu, K., Chiba, S., Kumano, K., Hosoya, N., Takahashi, T., Kanda, Y., Hamada, Y., Yazaki, Y. and Hirai, H. (1999). Mouse jagged1 physically interacts with notch2 and other notch receptors: assessment by quantitative methods. J. Biol. Chem. 274, 32961-32969.[Abstract/Free Full Text]

Struhl, G. and Adachi, A. (1998). Nuclear access and action of notch in vivo. Cell 93, 649-660.[CrossRef][Medline]

Struhl, G. and Greenwald, I. (1999). Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398, 522-525.[CrossRef][Medline]

Sun, X. and Artavanis-Tsakonas, S. (1997). Secreted forms of DELTA and SERRATE define antagonists of Notch signaling in Drosophila. Development 124, 3439-3448.[Abstract]

Tamura, K., Taniguchi, Y., Minoguchi, S., Sakai, T., Tun, T., Furukawa, T. and Honjo, T. (1995). Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H). Curr. Biol. 5, 1416-1423.[CrossRef][Medline]

Tsunematsu, R., Nakayama, K., Oike, Y., Nishiyama, M., Ishida, N., Hatakeyama, S., Bessho, Y., Kageyama, R., Suda, T. and Nakayama, K. I. (2004). Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. J. Biol. Chem. 279, 9417-9423.[Abstract/Free Full Text]

Vardar, D., North, C. L., Sanchez-Irizarry, C., Aster, J. C. and Blacklow, S. C. (2003). Nuclear magnetic resonance structure of a prototype Lin12-Notch repeat module from human Notch1. Biochemistry 42, 7061-7067.[CrossRef][Medline]

Wallberg, A. E., Pedersen, K., Lendahl, U. and Roeder, R. G. (2002). p300 and PCAF act cooperatively to mediate transcriptional activation from chromatin templates by notch intracellular domains in vitro. Mol. Cell. Biol. 22, 7812-7819.[Abstract/Free Full Text]

Wang, W. and Struhl, G. (2004). Drosophila Epsin mediates a select endocytic pathway that DSL ligands must enter to activate Notch. Development 131, 5367-5380.[Abstract/Free Full Text]

Wang, W. and Struhl, G. (2005). Distinct roles for Mind bomb, Neuralized and Epsin in mediating DSL endocytosis and signaling in Drosophila. Development 132, 2883-2894.[Abstract/Free Full Text]

Weng, A. P., Nam, Y., Wolfe, M. S., Pear, W. S., Griffin, J. D., Blacklow, S. C. and Aster, J. C. (2003). Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol. Cell. Biol. 23, 655-664.[Abstract/Free Full Text]

Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P. t., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T. and Aster, J. C. (2004). Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269-271.[Abstract/Free Full Text]

Wilson, J. J. and Kovall, R. A. (2006). Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA. Cell 124, 985-996.[CrossRef][Medline]

Wu, G., Lyapina, S., Das, I., Li, J., Gurney, M., Pauley, A., Chui, I., Deshaies, R. J. and Kitajewski, J. (2001). SEL-10 is an inhibitor of Notch signaling that targets Notch for ubiquitin-mediated protein degradation. Mol. Cell. Biol. 21, 7403-7415.[Abstract/Free Full Text]

Wu, L., Aster, J. C., Blacklow, S. C., Lake, R., Artavanis-Tsakonas, S. and Griffin, J. D. (2000). MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat. Genet. 26, 484-489.[CrossRef][Medline]

Xu, A., Lei, L. and Irvine, K. D. (2005). Regions of Drosophila Notch that contribute to ligand binding and the modulatory influence of Fringe. J. Biol. Chem. 280, 30158-30165.[Abstract/Free Full Text]

Ye, Y., Lukinova, N. and Fortini, M. E. (1999). Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature 398, 525-529.[CrossRef][Medline]

Yeh, E., Dermer, M., Commisso, C., Zhou, L., McGlade, C. J. and Boulianne, G. L. (2001). Neuralized functions as an E3 ubiquitin ligase during Drosophila development. Curr. Biol. 11, 1675-1679.[CrossRef][Medline]

Zweifel, M. E., Leahy, D. J., Hughson, F. M. and Barrick, D. (2003). Structure and stability of the ankyrin domain of the Drosophila Notch receptor. Protein Sci. 12, 2622-2632.[CrossRef][Medline]

Zweifel, M. E., Leahy, D. J. and Barrick, D. (2005). Structure and Notch receptor binding of the tandem WWE domain of Deltex. Structure 13, 1599-1611.[Medline]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. C. Bozkulak and G. Weinmaster Selective Use of ADAM10 and ADAM17 in Activation of Notch1 Signaling Mol. Cell. Biol., November 1, 2009; 29(21): 5679 - 5695. [Abstract] [Full Text] [PDF]

				H. S. Sul Minireview: Pref-1: Role in Adipogenesis and Mesenchymal Cell Fate Mol. Endocrinol., November 1, 2009; 23(11): 1717 - 1725. [Abstract] [Full Text] [PDF]

				H. O. Lee, J. M. Davidson, and R. J. Duronio Endoreplication: polyploidy with purpose Genes & Dev., November 1, 2009; 23(21): 2461 - 2477. [Abstract] [Full Text] [PDF]

				L. Luistro, W. He, M. Smith, K. Packman, M. Vilenchik, D. Carvajal, J. Roberts, J. Cai, W. Berkofsky-Fessler, H. Hilton, et al. Preclinical Profile of a Potent {gamma}-Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties Cancer Res., October 1, 2009; 69(19): 7672 - 7680. [Abstract] [Full Text] [PDF]

				Y. Yashiro-Ohtani, Y. He, T. Ohtani, M. E. Jones, O. Shestova, L. Xu, T. C. Fang, M. Y. Chiang, A. M. Intlekofer, S. C. Blacklow, et al. Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A Genes & Dev., July 15, 2009; 23(14): 1665 - 1676. [Abstract] [Full Text] [PDF]

				W. R. Gordon, M. Roy, D. Vardar-Ulu, M. Garfinkel, M. R. Mansour, J. C. Aster, and S. C. Blacklow Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL Blood, April 30, 2009; 113(18): 4381 - 4390. [Abstract] [Full Text] [PDF]

				T. Dai Notch Signaling and Cancer Am. Assoc. Cancer Res. Educ. Book, April 18, 2009; 2009(1): 71 - 79. [Full Text] [PDF]

				A.-C. Tien, A. Rajan, and H. J. Bellen A Notch updated J. Cell Biol., March 9, 2009; 184(5): 621 - 629. [Abstract] [Full Text] [PDF]

This Article Summary Figures Only Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gordon, W. R. Articles by Blacklow, S. C. Search for Related Content PubMed PubMed Citation Articles by Gordon, W. R. Articles by Blacklow, S. C. Social Bookmarking                         What's this?